GO:0042903 tubulin deacetylase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042903 (tubulin deacetylase activity) is a molecular function defined as the catalysis of the reaction N-acetyl(alpha-tubulin) + H2O = alpha-tubulin + acetate, i.e. removal of the acetyl group from lysine 40 of alpha-tubulin.
• HDAC6 is the best-characterized tubulin deacetylase; its activity links the tubulin cytoskeleton to immune synapse organization.
• Tubulin acetylation status is a key determinant of microtubule stability and dynamics, and its dysregulation is implicated in cancer, neurodegeneration, and immune dysfunction.
• Small-molecule inhibitors of tubulin deacetylases, such as rutin and crebinostat, increase alpha-tubulin acetylation and show therapeutic potential.
• Metabolic regulation of tubulin deacetylase activity, including HDAC6-catalyzed alpha-tubulin lactylation, reveals crosstalk between cellular metabolism and cytoskeletal function.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models are essential to dissect the causal roles of tubulin deacetylase genes in disease.
Description
Tubulin deacetylase activity (GO:0042903) is a molecular function that removes the acetyl group from N-acetyl(alpha-tubulin), yielding alpha-tubulin and acetate. This reversible post-translational modification occurs primarily on lysine 40 of alpha-tubulin and is a critical regulator of microtubule dynamics and stability. The balance between tubulin acetyltransferases and deacetylases controls the acetylation state of the microtubule cytoskeleton, which in turn influences processes such as intracellular transport, cell motility, and immune synapse formation. Researchers study this activity because its dysregulation is associated with cancer, neurodegenerative disorders, and immune-related diseases, and because it represents a druggable target for therapeutic intervention. The enzyme HDAC6 is the prototypical tubulin deacetylase, and its activity has been shown to link the tubulin cytoskeleton with immune synapse organization. More recently, metabolic regulation of cytoskeleton functions by HDAC6-catalyzed alpha-tubulin lactylation has been described, expanding the known roles of this enzyme beyond deacetylation. Understanding the molecular mechanisms, regulatory pathways, and disease relevance of tubulin deacetylase activity is therefore of broad biomedical importance.
tubulin deacetylase activity At A Glance
| GO ID | GO:0042903 |
|---|---|
| GO term | tubulin deacetylase activity |
| Ontology | molecular_function |
| Synonym | (none) |
| Major function | Catalysis of the removal of an acetyl group from alpha-tubulin, yielding alpha-tubulin and acetate |
| Reaction | N-acetyl(alpha-tubulin) + H2O = alpha-tubulin + acetate |
| Substrate | N-acetyl(alpha-tubulin), specifically acetylated lysine 40 |
| Product | alpha-tubulin and acetate |
| Cellular context | Microtubule cytoskeleton; cytoplasm; immune synapse |
| Representative enzyme | HDAC6 (histone deacetylase 6) |
| Disease relevance | Cancer, neurodegeneration, immune disorders |
What Is GO:0042903?
Tubulin deacetylase activity (GO:0042903) is defined by the Gene Ontology as the catalysis of the reaction: N-acetyl(alpha-tubulin) + H2O = alpha-tubulin + acetate. In other words, it is the enzymatic removal of an acetyl group from the alpha-tubulin protein, specifically from the epsilon-amino group of lysine 40. This activity is a type of histone deacetylase activity that acts on a non-histone substrate, and it is distinct from tubulin acetyltransferase activity, which adds the acetyl group. The reaction is hydrolytic and requires water. The official synonym list is empty, but the term is commonly referred to as alpha-tubulin deacetylase activity or tubulin deacetylation.
Why Is tubulin deacetylase activity Important in Cell Biology?
Tubulin deacetylase activity is important because it controls the acetylation state of alpha-tubulin, a modification that directly influences microtubule stability, dynamics, and interactions with microtubule-associated proteins. This activity is essential for normal cellular processes such as cell division, intracellular transport, and immune synapse organization. Dysregulation of tubulin deacetylation has been implicated in cancer, where altered microtubule dynamics contribute to tumor progression and drug resistance. In the nervous system, changes in tubulin acetylation are associated with neurodegenerative conditions and memory formation. Moreover, tubulin deacetylase inhibitors are being explored as anticancer and neuroprotective agents. The recent discovery that HDAC6 can also catalyze alpha-tubulin lactylation highlights the broader metabolic regulation of cytoskeletal functions. Thus, understanding tubulin deacetylase activity is crucial for both basic cell biology and translational medicine.
• Regulates microtubule stability and dynamics, affecting cell shape, motility, and division.
• Controls immune synapse organization and T-cell activation.
• Implicated in cancer progression and as a target for anticancer drugs.
• Linked to memory formation and neurodegenerative diseases.
• Modulated by natural compounds such as rutin, which inhibits HDAC6 and increases alpha-tubulin acetylation.
• Involved in metabolic regulation through alpha-tubulin lactylation.
• Affects muscle cell senescence via microtubule hyper-stabilization.
• Potential role in autophagy regulation through ULK1 and KAT2A/GCN5-mediated acetylation.
• Target of dual inhibitors that co-target tubulin and histone deacetylase 1.
• Provides a mechanism for crosstalk between cytoskeleton and epigenetic regulation.
Molecular Mechanism of tubulin deacetylase activity
Substrate recognition and binding
In simple terms: The enzyme finds and grabs the acetylated alpha-tubulin protein.
Tubulin deacetylases, such as HDAC6, recognize and bind to acetylated alpha-tubulin, primarily at lysine 40. This binding is mediated by the enzyme's catalytic domain and possibly additional domains that target it to the microtubule cytoskeleton. The interaction is dynamic and can be influenced by the microtubule network and associated proteins.
Catalytic mechanism of deacetylation
In simple terms: The enzyme uses water to cut off the acetyl group from alpha-tubulin.
The deacetylation reaction is hydrolytic: a water molecule attacks the acetyl-lysine bond, releasing acetate and leaving the free epsilon-amino group of lysine 40 on alpha-tubulin. This reaction is catalyzed by a zinc-dependent mechanism typical of histone deacetylases. The activity of HDAC6 is essential for this process, as demonstrated by studies showing that HDAC6 deacetylase activity links the tubulin cytoskeleton with immune synapse organization.
Cofactors and metal dependence
In simple terms: The enzyme needs a zinc ion to work.
Tubulin deacetylases belong to the zinc-dependent histone deacetylase family. The catalytic mechanism requires a zinc ion in the active site, which activates the water molecule for nucleophilic attack. This is consistent with the general mechanism of HDAC enzymes. Inhibitors such as hydroxamic acid derivatives chelate the zinc ion, thereby blocking deacetylation.
Regulation by post-translational modifications and metabolic cues
In simple terms: The enzyme's activity can be turned up or down by other chemical changes and by the cell's metabolism.
Tubulin deacetylase activity is regulated by various post-translational modifications and metabolic signals. For example, HDAC6 can catalyze alpha-tubulin lactylation, which affects cytoskeleton functions and links metabolism to the cytoskeleton. Additionally, deletion of ULK1 enhances KAT2A/GCN5-mediated acetylation of TUBA/alpha-tubulin, indirectly reducing deacetylation. These findings indicate that tubulin deacetylase activity is integrated into cellular metabolic and signaling networks.
Inhibitors and pharmacological modulation
In simple terms: Drugs can block the enzyme, leading to more acetylated tubulin.
Several small molecules inhibit tubulin deacetylase activity. Rutin, a natural flavonoid, increases alpha-tubulin acetylation via HDAC6 inhibition. Crebinostat, a synthetic compound, facilitates memory formation and likely acts through inhibition of HDAC6. Dual inhibitors that co-target tubulin and histone deacetylase 1 have potent anticancer activity. These pharmacological tools are valuable for studying the consequences of tubulin deacetylation.
Key Genes Involved in GO:0042903 tubulin deacetylase activity
The following genes and proteins are directly or indirectly involved in tubulin deacetylase activity, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HDAC6 | Primary tubulin deacetylase; removes acetyl group from alpha-tubulin | Central enzyme for tubulin deacetylation; linked to immune synapse and cancer |
| TUBA1A | Alpha-tubulin isoform; substrate for deacetylation at Lys40 | Mutations affect microtubule stability; target for acetylation studies |
| TUBA1B | Alpha-tubulin isoform; substrate for deacetylation | Commonly used as model substrate in tubulin acetylation assays |
| KAT2A (GCN5) | Histone acetyltransferase that acetylates alpha-tubulin | Counteracts deacetylation; deletion of ULK1 enhances its activity |
| ULK1 | Autophagy kinase; regulates KAT2A/GCN5-mediated tubulin acetylation | Deletion increases tubulin acetylation and inhibits neointima formation |
| SIRT2 | NAD+-dependent tubulin deacetylase | Alternative deacetylase for alpha-tubulin; studied in neurodegeneration |
| HDAC1 | Histone deacetylase; can deacetylate tubulin in some contexts | Target of dual inhibitors with anticancer activity |
| HDAC2 | Histone deacetylase; potential tubulin deacetylase | Implicated in epigenetic regulation and cancer |
| HDAC3 | Histone deacetylase; may contribute to tubulin deacetylation | Part of the broader HDAC family |
| HDAC8 | Histone deacetylase; potential tubulin deacetylase | Studied for its role in cytoskeletal dynamics |
| HDAC10 | Histone deacetylase; potential tubulin deacetylase | Less characterized; may regulate tubulin acetylation |
| EP300 | Histone acetyltransferase; can acetylate tubulin | Balances deacetylation; affects microtubule stability |
| CREBBP | Histone acetyltransferase; acetylates alpha-tubulin | Counteracts deacetylation; involved in memory formation |
| MAPT (Tau) | Microtubule-associated protein; binds tubulin | Tau pathology linked to altered tubulin acetylation in neurodegeneration |
| ATG5 | Autophagy-related protein; affects microtubule dynamics | Cross-talk between autophagy and tubulin acetylation |
| ATG7 | Autophagy-related protein; modulates tubulin acetylation | Influences deacetylation indirectly |
| SQSTM1 (p62) | Autophagy receptor; interacts with HDAC6 | Links deacetylation to protein aggregation diseases |
| LRRK2 | Kinase implicated in Parkinson's disease; interacts with microtubules | May regulate tubulin deacetylation in neurodegeneration |
How Is tubulin deacetylase activity Regulated?
Tubulin deacetylase activity is regulated at multiple levels. The expression and activity of HDAC6, the primary tubulin deacetylase, can be modulated by signaling pathways such as those involving autophagy-related kinases. For instance, deletion of ULK1 enhances KAT2A/GCN5-mediated acetylation of TUBA/alpha-tubulin, thereby shifting the balance away from deacetylation. Metabolic cues also play a role: HDAC6-catalyzed alpha-tubulin lactylation affects cytoskeleton functions, indicating that cellular metabolism can directly influence tubulin deacetylase activity. Additionally, post-translational modifications of HDAC6 itself, such as phosphorylation and ubiquitination, can alter its activity and localization. Pharmacological inhibitors, including rutin and crebinostat, can acutely modulate tubulin deacetylase activity. Thus, regulation is complex and integrated with cellular stress, metabolic, and signaling networks.
tubulin deacetylase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HDAC6 | Cancer, immune disorders | HDAC6 knockout cancer cell lines; xenograft models |
| TUBA1A | Neurodevelopmental disorders | Knock-in mice with acetylation-mimetic or deacetylation-deficient mutations |
| KAT2A | Cancer, cardiovascular disease | KAT2A knockout or overexpression in vascular smooth muscle cells |
| ULK1 | Neointima formation, autophagy | ULK1 knockout mice; vascular injury models |
| MAPT | Alzheimer's disease, tauopathies | Tau transgenic mice; HDAC6 inhibitor treatment |
Cancer
Tubulin deacetylase activity is frequently dysregulated in cancer. HDAC6 is overexpressed in many malignancies, and its deacetylation of alpha-tubulin promotes microtubule dynamics that support tumor cell proliferation, migration, and invasion. Inhibitors of tubulin deacetylase, such as dual-acting compounds that target both tubulin and HDAC1, have shown potent anticancer activity in vitro and in vivo. Furthermore, chiral 1,4-diarylazetidin-2-one-based hydroxamic acid derivatives act as tubulin polymerization inhibitors with histone deacetylase inhibitory activity, highlighting the therapeutic potential of targeting this activity.
Neurodegeneration and memory
Altered tubulin acetylation is implicated in neurodegenerative diseases and cognitive function. Crebinostat, a histone deacetylase inhibitor, facilitates memory formation, likely by increasing alpha-tubulin acetylation. In models of neurodegeneration, changes in tubulin deacetylase activity can affect microtubule stability and neuronal transport, contributing to pathology. For example, tau pathology is associated with altered tubulin acetylation, and modulating HDAC6 activity may be protective.
Immune synapse and autoimmunity
HDAC6 deacetylase activity links the tubulin cytoskeleton with immune synapse organization, a critical process for T-cell activation. Dysregulation of this activity can impair immune responses and contribute to autoimmune diseases. Therefore, tubulin deacetylase inhibitors are being explored as immunomodulatory agents.
Muscle senescence and environmental stress
Recent studies show that polystyrene nanoplastics promote muscle cell senescence through microtubule hyper-stabilization-mediated mitophagy dysfunction and cGAS-STING activation, a process that may involve altered tubulin deacetylation. This suggests that environmental stressors can impact tubulin deacetylase activity and contribute to age-related muscle dysfunction.
From tubulin deacetylase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of HDAC6 affect tubulin acetylation and immune synapse formation? | HDAC6 knockout Jurkat or primary T cells |
| Does a point mutation in the catalytic domain of HDAC6 abolish deacetylase activity? | HDAC6 point-mutant knock-in cell lines |
| Does overexpression of SIRT2 alter tubulin acetylation and neurodegeneration? | SIRT2 overexpression in neuronal cell lines or mice |
| Does knock-in of acetylation-mimetic alpha-tubulin affect microtubule dynamics? | TUBA1A K40Q knock-in mice or cells |
| Does knockout of ULK1 increase tubulin acetylation and inhibit neointima formation? | ULK1 knockout mice subjected to vascular injury |
| Can CRISPR activation of KAT2A compensate for HDAC6 inhibition? | CRISPRa KAT2A in HDAC6-inhibited cells |
How to Study the tubulin deacetylase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Western blot with anti-acetyl-alpha-tubulin | Levels of acetylated alpha-tubulin | Assessing deacetylase activity in cells |
| In vitro HDAC activity assay | Enzymatic release of acetate from acetylated substrate | Testing inhibitors or recombinant enzyme activity |
| Immunofluorescence microscopy | Spatial distribution of acetylated microtubules | Studying cytoskeleton organization |
| CRISPR knockout screen | Genes required for tubulin deacetylation | Identifying novel regulators |
| Mass spectrometry acetylproteomics | Global acetylation changes | Mapping deacetylation targets |
| Flow cytometry with acetylation marker | Cell population acetylation levels | Sorting cells for screens |
| Co-immunoprecipitation | Protein-protein interactions with HDAC6 | Identifying complexes |
| qRT-PCR | mRNA expression of HDAC6 and related genes | Validating knockout or overexpression |
Western blotting with acetylation-specific antibodies
Immunoblotting using antibodies against acetylated alpha-tubulin (Lys40) is the standard method to measure tubulin deacetylase activity indirectly. Decreased acetylation indicates higher deacetylase activity, while increased acetylation suggests inhibition or reduced activity.
In vitro deacetylase assays
Recombinant HDAC6 or cell lysates can be incubated with acetylated alpha-tubulin or synthetic acetyl-lysine substrates, and the release of acetate or the decrease in acetylation can be quantified using fluorogenic or mass spectrometry-based assays.
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens can identify genes that regulate tubulin acetylation. Cells are stained with anti-acetyl-alpha-tubulin antibodies and sorted by flow cytometry to enrich for regulators.
Proteomics and acetylome analysis
Mass spectrometry-based acetylproteomics can quantify acetylation changes on alpha-tubulin and other proteins following genetic or pharmacological perturbation of tubulin deacetylases.
How CRISPR Can Be Used to Study GO:0042903 tubulin deacetylase activity
Knockout
CRISPR knockout of HDAC6 or other tubulin deacetylase genes eliminates their activity, leading to hyperacetylation of alpha-tubulin. This approach is used to study the consequences of loss of deacetylation on microtubule dynamics, immune synapse formation, and cancer cell proliferation. Knockout of ULK1 increases tubulin acetylation and inhibits neointima formation, demonstrating the utility of CRISPR in uncovering regulatory networks.
Point Mutation
CRISPR-mediated point mutations can be introduced into the catalytic domain of HDAC6 to abolish deacetylase activity while preserving protein structure. Such models are valuable to distinguish enzymatic activity from scaffolding functions. Similarly, point mutations in alpha-tubulin at Lys40 (e.g., K40Q or K40R) can mimic or prevent acetylation, respectively, to dissect the role of this modification.
Knock-in
Knock-in of tagged HDAC6 (e.g., GFP or HA) allows for live-cell imaging and proteomic analysis of the enzyme. Knock-in of acetylation-mimetic alpha-tubulin (K40Q) or deacetylation-deficient (K40R) variants provides powerful tools to study the impact of tubulin acetylation on cellular functions.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of HDAC6, SIRT2, or KAT2A can be used to increase or decrease tubulin acetylation levels. Overexpression of HDAC6 enhances deacetylation and promotes cell migration, while overexpression of KAT2A increases acetylation and stabilizes microtubules.
How EDITGENE Supports tubulin deacetylase activity Research
Researchers studying tubulin deacetylase activity-related genes often need to determine whether a candidate gene is causally involved in the regulation of microtubule acetylation, immune synapse function, or disease progression. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models that enable such causal studies.
Contact EDITGENE today to design your custom CRISPR model for tubulin deacetylase activity research.
Frequently Asked Questions About tubulin deacetylase activity
What is tubulin deacetylase activity?
Tubulin deacetylase activity (GO:0042903) is the enzymatic removal of an acetyl group from alpha-tubulin, producing alpha-tubulin and acetate. It is a molecular function that regulates microtubule stability.
What genes are involved in tubulin deacetylase activity?
The primary gene is HDAC6, which encodes a tubulin deacetylase. Other genes include SIRT2, HDAC1, HDAC2, and KAT2A (which counteracts deacetylation).
Which enzyme is the main tubulin deacetylase?
HDAC6 is the best-characterized tubulin deacetylase, and its activity is essential for immune synapse organization and cytoskeletal regulation.
How is tubulin deacetylase activity measured?
It is commonly measured by Western blot with antibodies against acetylated alpha-tubulin (Lys40), or by in vitro deacetylase assays using recombinant enzyme and acetylated substrates.
What diseases are associated with tubulin deacetylase activity?
Dysregulation is linked to cancer, neurodegenerative diseases, immune disorders, and muscle senescence.
Can tubulin deacetylase activity be inhibited?
Yes, inhibitors such as rutin, crebinostat, and hydroxamic acid derivatives block HDAC6 and increase alpha-tubulin acetylation.
What is the role of HDAC6 in immune synapse?
HDAC6 deacetylase activity links the tubulin cytoskeleton with immune synapse organization, affecting T-cell activation.
How does ULK1 affect tubulin acetylation?
Deletion of ULK1 enhances KAT2A/GCN5-mediated acetylation of TUBA/alpha-tubulin, thereby reducing deacetylation.
What is alpha-tubulin lactylation?
HDAC6 can catalyze alpha-tubulin lactylation, a metabolic modification that regulates cytoskeleton functions.
What CRISPR models are available for studying tubulin deacetylase activity?
EDITGENE offers knockout, point mutation, knock-in, overexpression, and library screening services for HDAC6 and related genes.
Conclusion
Tubulin deacetylase activity (GO:0042903) is a fundamental molecular function that controls the acetylation state of alpha-tubulin, with far-reaching implications for cytoskeletal dynamics, immune function, cancer, and neurodegeneration. The enzyme HDAC6 is the primary mediator, and its activity is regulated by metabolic and signaling pathways. Pharmacological inhibitors and CRISPR-based genetic models are invaluable tools for dissecting the mechanisms and therapeutic potential of targeting this activity. Continued research into tubulin deacetylase activity will likely yield new insights into disease pathogenesis and novel treatment strategies.
References
- 1. Sun S et al.. 2024. Metabolic regulation of cytoskeleton functions by HDAC6-catalyzed α-tubulin lactylation.. Nat Commun 15(1):8377 PMID: 39333081
- 2. Li YR et al.. 2022. A novel aromatic amide derivative SY-65 co-targeted tubulin and histone deacetylase 1 with potent anticancer activity in vitro and in vivo.. Biochem Pharmacol 201:115070 PMID: 35526597
- 3. Dama D et al.. 2024. Crebinostat facilitates memory formation.. Biochem Biophys Res Commun 710:149872 PMID: 38593621
- 4. Çetin Ö et al.. 2022. Rutin increases alpha-tubulin acetylation via histone deacetylase 6 inhibition.. Drug Dev Res 83(4):993-1002 PMID: 35266183
- 5. Ouyang C et al.. 2021. Deletion of Ulk1 inhibits neointima formation by enhancing KAT2A/GCN5-mediated acetylation of TUBA/α-tubulin in vivo.. Autophagy 17(12):4305-4322 PMID: 33985412
- 6. Serrador JM et al.. 2004. HDAC6 deacetylase activity links the tubulin cytoskeleton with immune synapse organization.. Immunity 20(4):417-28 PMID: 15084271
- 7. Cui J et al.. 2025. Polystyrene nanoplastics promote muscle cell senescence through microtubule hyper-stabilization-mediated mitophagy dysfunction and cGAS-Sting activation.. J Hazard Mater 496:139232 PMID: 40664082
- 8. Tang H et al.. 2023. Discovery of chiral 1,4-diarylazetidin-2-one-based hydroxamic acid derivatives as novel tubulin polymerization inhibitors with histone deacetylase inhibitory activity.. Bioorg Med Chem 92:117437 PMID: 37563016
